CF ON3 Lifesciences Parent DST 2026: Is It Legit? Form D Raise, Investors, Who Is Behind It

Q: What is CF ON3 Lifesciences Parent DST?

CF ON3 Lifesciences Parent DST is a Delaware entity that filed a Form D with the SEC on February 28, 2023 in the Other Real Estate industry group. The filing claims Rule 506(b) for an offering of equity.

Q: Is CF ON3 Lifesciences Parent DST legit?

AltStreet does not rate legitimacy; it reports the public record. CF ON3 Lifesciences Parent DST filed a Form D with the SEC on February 28, 2023 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $69,800,000 sold to 116 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Q: Is CF ON3 Lifesciences Parent DST registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that CF ON3 Lifesciences Parent DST claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

Q: How much has CF ON3 Lifesciences Parent DST raised?

CF ON3 Lifesciences Parent DST reported $69,800,000 sold from 116 investors of a $69,800,000 total offering as of the Form D filed February 28, 2023.

Q: Who can invest in CF ON3 Lifesciences Parent DST?

The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $250,000.

Q: What is the minimum investment in CF ON3 Lifesciences Parent DST?

The Form D lists $250,000 as the minimum investment accepted from any outside investor as of February 28, 2023. Issuers can waive their own minimums, and the figure does not include fees.

Q: Who is selling CF ON3 Lifesciences Parent DST and how are they paid?

The Form D names Cantor Fitzgerald & Co. (CRD 134), associated with None; Great Point Capital LLC (CRD 114203), associated with None; Nationwide Planning Associates, Inc. (CRD 31029), associated with None; Emerson Equity, LLC (CRD 130032), associated with None and 25 others as recipients of sales compensation soliciting in all states.

Q: Who is behind CF ON3 Lifesciences Parent DST?

The Form D lists 4 related persons: Cantor Fitzgerald Investors, LLC, executive officer (Sponsor of the Issuer); CF ON3 Lifesciences DST Manager, LLC, executive officer (Operating Administrative Trustee); CF ON3 Lifesciences Parent Manager, LLC, executive officer (Parent Administrative Trustee); CF ON3 Lifesciences Depositor, LLC, executive officer (Depositor). Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Q: Where is CF ON3 Lifesciences Parent DST located?

The issuer's address on its SEC filings is C/O Cantor Fitzgerald Investors, LLC, 110 East 59th Street, New York, NY 10022. Its phone number of record is 2129385000. It is organized under the laws of Delaware.

Q: How long is the CF ON3 Lifesciences Parent DST offering open?

The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 1 amendment is on record for this CIK.

AltStreetEDGAR DatabaseCF ON3 Lifesciences Parent DST
SEC filing record
Primary Source · SEC.gov
CF ON3 Lifesciences Parent DST2022 vintageRule 506(b)Filing record
Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.
Raised
$70M
Investors
116
Min Invest
$250,000
Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.
Claim freeVerify, $480/yr
What this filing shows·Every sentence is a value as filed on SEC Form D
CF ON3 Lifesciences Parent DST is a Delaware entity that first filed a Form D on May 23, 2022 and most recently amended it on February 28, 2023 in the Other Real Estate industry group. The offering claims Rule 506(b) and covers equity. CF ON3 Lifesciences Parent DST reported $69,800,000 sold from 116 investors of a $69,800,000 total offering as of the Form D filed February 28, 2023. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $250,000. The Form D names Cantor Fitzgerald & Co. (CRD 134), associated with None; Great Point Capital LLC (CRD 114203), associated with None; Nationwide Planning Associates, Inc. (CRD 31029), associated with None; Emerson Equity, LLC (CRD 130032), associated with None and 25 others as recipients of sales compensation soliciting in all states. The issuer's address of record is C/O Cantor Fitzgerald Investors, LLC, 110 East 59th Street, New York, NY 10022.
EDGAR Filing Data
Form D — Primary Source
View on SEC.gov 
CIK Number0001928276
Entity NameCF ON3 Lifesciences Parent DST
ExemptionRule 506(b)
What the exemption meansRule 506(b) of Regulation D: securities may be sold to an unlimited number of accredited investors and up to 35 non-accredited investors who meet the rule's sophistication standard, without general solicitation or advertising.
Entity TypeOther
Jurisdiction of OrganizationDelaware
Issuer AddressC/O Cantor Fitzgerald Investors, LLC, 110 East 59th Street, New York, NY 10022
Phone(212) 938-5000
Industry / Fund TypeOther Real Estate
Securities TypeEquity
First Sale DateMay 11, 2022
Filing DateFebruary 28, 2023
Accession Number0001928276-23-000001
Total Offering Amount$69,800,000
Total Amount Sold$69,800,000
Amount Remaining$0
Total Investors116
Non-Accredited InvestorsNone
Minimum Investment$250,000
Offering DurationOne year or less
Revenue RangeDecline to Disclose
State (Issuer Address)NY
Amendment Count2 filings on record
Filings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
D/AFebruary 28, 20230001928276-23-000001DMay 23, 20220001928276-22-000001
In the Terminal
Filing events
0
none on file
Critical / warning
0 / 0
0 watch · 0 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
1
closed
Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.
Investor
1 offering timeline: velocity, share raised, first-sale lag, stalled flags
Pro
This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Cantor Fitzgerald Investors, LLC
Executive Officer · New York, NY
Sponsor of the Issuer
CF ON3 Lifesciences DST Manager, LLC
Executive Officer · New York, NY
Operating Administrative Trustee
CF ON3 Lifesciences Parent Manager, LLC
Executive Officer · New York, NY
Parent Administrative Trustee
CF ON3 Lifesciences Depositor, LLC
Executive Officer · New York, NY
Depositor
Placement Agents and Sales Compensation (Form D)
Who the issuer reported paying to sell the securities (Form D Item 12), with the FINRA registration number the filer gave. Source: SEC.gov.
Cantor Fitzgerald & Co.CRD 134 on BrokerCheck 
Associated broker-dealer: None · New York, NY · Soliciting in all states
Great Point Capital LLCCRD 114203 on BrokerCheck 
Associated broker-dealer: None · Chicago, IL · Soliciting in CO, NY
Nationwide Planning Associates, Inc.CRD 31029 on BrokerCheck 
Associated broker-dealer: None · Paramus, NJ · Soliciting in NJ, NY
Emerson Equity, LLCCRD 130032 on BrokerCheck 
Associated broker-dealer: None · San Mateo, CA · Soliciting in CA, CO, TN, TX, WA
Metropolitan Capital Investment Banc, Inc.CRD 148820 on BrokerCheck 
Associated broker-dealer: None · Chicago, IL · Soliciting in CO, MO, PA
AAG Capital, Inc.CRD 188 on BrokerCheck 
Associated broker-dealer: None · Wesley Chapel, FL · Soliciting in FL, LA, VA
Concorde Investments Services, LLCCRD 151604 on BrokerCheck 
Associated broker-dealer: None · Livonia, MI · Soliciting in CA, MA, MO, NY, RI, TN
FNEX Capital, LLCCRD 166316 on BrokerCheck 
Associated broker-dealer: None · Indianapolis, IN · Soliciting in OH
APW Capital, Inc.CRD 43814 on BrokerCheck 
Associated broker-dealer: None · Rockaway, NJ · Soliciting in CA
Lightpath Capital, Inc.CRD 34617 on BrokerCheck 
Associated broker-dealer: None · Southlake, TX · Soliciting in CA, NY, WA
Whitehall-Parker Securities, Inc.CRD 10608 on BrokerCheck 
Associated broker-dealer: None · San Rafael, CA · Soliciting in CA
Aurora SecuritiesCRD 46147 on BrokerCheck 
Associated broker-dealer: None · Troy, MI · Soliciting in CA, WA
DAI Securities, LLCCRD 36673 on BrokerCheck 
Associated broker-dealer: None · Atlanta, GA · Soliciting in CA, FL, ID, NY
The Strategic Financial Alliance, Inc.CRD 126514 on BrokerCheck 
Associated broker-dealer: None · Atlanta, GA · Soliciting in NY
Cambridge Investment Research, Inc.CRD 39543 on BrokerCheck 
Associated broker-dealer: None · Fairfield, IA · Soliciting in CA, FL, IL
Dempsey Lord Smith, LLCCRD 141238 on BrokerCheck 
Associated broker-dealer: None · Rome, GA · Soliciting in GA
Madison Avenue Securities, LLCCRD 23224 on BrokerCheck 
Associated broker-dealer: None · San Diego, CA · Soliciting in KY, VA
Colorado Financial Service CorporationCRD 104343 on BrokerCheck 
Associated broker-dealer: None · Centennial, CO · Soliciting in CA, CT, FL
Wealthforge Securities, LLCCRD 152550 on BrokerCheck 
Associated broker-dealer: None · Richmond, VA · Soliciting in CA
Centaurus Financial, Inc.CRD 30833 on BrokerCheck 
Associated broker-dealer: None · Anaheim, CA · Soliciting in CA, FL, NV, SC
Saxony Securities, Inc.CRD 115547 on BrokerCheck 
Associated broker-dealer: None · St. Louis, MO · Soliciting in CO
Berthel, Fisher & Company Financial Services, Inc.CRD 13609 on BrokerCheck 
Associated broker-dealer: None · Cedar Rapids, IA · Soliciting in IL, NE
Purshe Kaplan Sterling InvestmentsCRD 35747 on BrokerCheck 
Associated broker-dealer: None · Albany, NY · Soliciting in CO
Calton & Associates, Inc.CRD 20999 on BrokerCheck 
Associated broker-dealer: None · Tampa, FL · Soliciting in TX
Kestra Investment Services, LLCCRD 42046 on BrokerCheck 
Associated broker-dealer: None · Austin, TX · Soliciting in TX
Realized Financial, Inc.CRD 22333 on BrokerCheck 
Associated broker-dealer: None · Austin, TX · Soliciting in CA, MA, MD, UT
World Equity Group, Inc.CRD 29087 on BrokerCheck 
Associated broker-dealer: None · Arlington Heights, IL · Soliciting in IL
Private Client Services, LLCCRD 120222 on BrokerCheck 
Associated broker-dealer: None · Louisville, KY · Soliciting in WA
McDermott Investment Services, LLCCRD 154926 on BrokerCheck 
Associated broker-dealer: None · Bethlehem, PA · Soliciting in CA
Questions About CF ON3 Lifesciences Parent DST
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is CF ON3 Lifesciences Parent DST?CF ON3 Lifesciences Parent DST is a Delaware entity that filed a Form D with the SEC on February 28, 2023 in the Other Real Estate industry group. The filing claims Rule 506(b) for an offering of equity.
Is CF ON3 Lifesciences Parent DST legit?AltStreet does not rate legitimacy; it reports the public record. CF ON3 Lifesciences Parent DST filed a Form D with the SEC on February 28, 2023 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $69,800,000 sold to 116 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is CF ON3 Lifesciences Parent DST registered with or approved by the SEC?No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that CF ON3 Lifesciences Parent DST claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has CF ON3 Lifesciences Parent DST raised?CF ON3 Lifesciences Parent DST reported $69,800,000 sold from 116 investors of a $69,800,000 total offering as of the Form D filed February 28, 2023.
Who can invest in CF ON3 Lifesciences Parent DST?The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $250,000.
What is the minimum investment in CF ON3 Lifesciences Parent DST?The Form D lists $250,000 as the minimum investment accepted from any outside investor as of February 28, 2023. Issuers can waive their own minimums, and the figure does not include fees.
Who is selling CF ON3 Lifesciences Parent DST and how are they paid?The Form D names Cantor Fitzgerald & Co. (CRD 134), associated with None; Great Point Capital LLC (CRD 114203), associated with None; Nationwide Planning Associates, Inc. (CRD 31029), associated with None; Emerson Equity, LLC (CRD 130032), associated with None and 25 others as recipients of sales compensation soliciting in all states.
Who is behind CF ON3 Lifesciences Parent DST?The Form D lists 4 related persons: Cantor Fitzgerald Investors, LLC, executive officer (Sponsor of the Issuer); CF ON3 Lifesciences DST Manager, LLC, executive officer (Operating Administrative Trustee); CF ON3 Lifesciences Parent Manager, LLC, executive officer (Parent Administrative Trustee); CF ON3 Lifesciences Depositor, LLC, executive officer (Depositor). Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is CF ON3 Lifesciences Parent DST located?The issuer's address on its SEC filings is C/O Cantor Fitzgerald Investors, LLC, 110 East 59th Street, New York, NY 10022. Its phone number of record is 2129385000. It is organized under the laws of Delaware.
How long is the CF ON3 Lifesciences Parent DST offering open?The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 1 amendment is on record for this CIK.
What is CF ON3 Lifesciences Parent DST's revenue?The issuer declined to disclose its revenue range on the Form D, which the form permits.
Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.
Claim this profile, freeVerify this entity, $480/yr
Also filed in February 2023
iCapital-Blackstone SP IX US Access Fund, L.P.
$990MBREP X Commercial Real Estate Fund, L.P.
$444MiCapital-Blackstone SP IX Offshore Access Fund, L.P.
$209MDraco Capital Macro Quant Fund, LP
$6MWholesome Spirits Inc.
$5MCAIS EQT Buyout Fund X Access, L.P.
$2MRapha Capital PE Life Sciences Fund VI, LP
$1MAsana Partners Fund III REIT 6, LLC
$875KEquityZen Growth Technology Fund LLC - Series 1603
$552KEquityZen Growth Technology Fund LLC - Series 1590
$542KEquityZen Growth Technology Fund LLC - Series 1522
$474KEquitybee 22-67608, a Series of Equitybee cFund Master LLC
$256K
Largest other real estate filers, this year and last
Prologis Targeted U.S. Logistics Holdings, L.P.206 investors
$18.2BPrologis European Logistics Fund231 investors
$11.4BTA Realty Core Property Fund, LP368 investors
$5.3BVentas Life Science & Healthcare Real Estate Fund, L.P.32 investors
$2.1BPrologis Targeted U.S. Logistics REIT, Inc.301 investors
$1.9BPrologis China Core Logistics Fund, LP12 investors
$1.8BWheelock Street Real Estate Long Term Value Fund, LP45 investors
$1.3BNorthPoint Industrial Fund VII, LP627 investors
$1.3BNorthPoint Growth & Income Partners, LP392 investors
$1.3BCapital Fund II, LLC1,149 investors
$1.0BHoward Hughes Holdings Inc.1 investors
$1000MRMS Evergreen US Forestland Fund LP20 investors
$828M
All other real estate issuers →Filed in February 2023 →
Also filed in February 2023
HF Marketable Securities Pool, LLC28 investors
$5.5BHPS Offshore Strategic Investment Partners V, L.P.85 investors
$5.0BHPS Strategic Investment Partners V, L.P.109 investors
$3.0BPSG Europe II L.P.117 investors
$2.6BPSG Europe (Lux) II S.C.Sp.117 investors
$2.6BGlendower Capital Secondary Opportunities Fund V, SCSp22 investors
$2.4BCrow Holdings Realty Partners X, L.P.124 investors
$2.3BAlphaCat Opportunities Ltd.27 investors
$2.2BGlendower Capital SOF V (Feeder A), SCSp90 investors
$2.2BErgoteles International Ltd76 investors
$1.8BAres European Real Estate Fund VI SCSp11 investors
$1.6BBLUE ROCK CAPITAL FUND, L.P.37 investors
$1.5B
All other real estate issuers →Filed in February 2023 →
EDGAR Links
All FilingsEDGAR Full Text SearchSEC Submissions API
Understand This Filing
How Form D private placements workAccredited investor requirementsAlternative-investment glossary
AltStreet Pro
Compare across asset classes
Pro subscribers access the Intelligence Terminal - normalized comparison of 100+ platforms across every alternative asset class.
Terminal plans from $149/month 
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.